Paccagnella, A <br/><br/>
Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.  [electronic resource] 

 -  Cancer  Jun 1990 
 - 2631-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19900615)65:12<2631::aid-cncr2820651205>3.0.co;2-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Drug Evaluation<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Remission Induction